Azienda Sanitaria Locale Di Salerno
- Address
- Via Nizza 146, 84124 Battipaglia, Italy
Hemic and Lymphatic Diseases
Research at Azienda Sanitaria Locale Di Salerno focuses on Acute Myeloid Leukemia patients carrying a FLT3 mutation, exploring how early treatment intensification and biomarker‑driven decisions can improve event‑free survival.
- Biomarker‑guided therapy selection
- Early high‑dose induction strategies
- Integration of allogeneic transplant pathways
The program aims to personalize care for high‑risk leukemia, offering hope for better long‑term outcomes.
Respiratory Tract Diseases
The department conducts a study on Asthma evaluating a single inhaler therapy that combines ICS/LABA/LAMA agents versus a traditional dual inhaler approach, with the goal of enhancing disease control over a year.
- Comparative effectiveness of triple versus dual inhaler regimens
- Long‑term impact on asthma symptom scores
- Patient‑reported quality‑of‑life outcomes
Findings are expected to inform optimal inhaler strategies for everyday asthma management.
Mental Disorders
A trial investigates Major Depressive Disorder with Insomnia Symptoms, testing the addition of seltorexant to existing SSRI/SNRI therapy to improve mood and prevent relapse in individuals who have not responded adequately to standard treatment.
- Adjunctive use of novel sleep‑modulating agents
- Prevention of depressive symptom recurrence
- Assessment of safety for short‑ and long‑term use
This research seeks to expand therapeutic options for patients struggling with depression and sleep disturbances.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 5 therapeutic areas and 15 of 43 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Sanitaria Locale Di Salerno
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial | Biogen Idec Research Limited | Phase III | Not Recruiting | Feb 2022 | — |
IMP list
lock Showing 1 of 43 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 6 | Unknown | 2018-10-26 | 2022-10-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.